Scholars Central

Conference abstractPublished 12 Sep 2016

Recent progression in hemophilia gene therapy

Authors: Reyhane Sadat Saeedi, Ali Hosseini Bereshneh, Saeed Tarverdizadeh, Mohammad Roshanghalb, Reza Roodbarani

Tehran University of Medical Sciences, Iran

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hemophilia is a bleeding disorder in which coagulation is corrupted. There are different types of Hemophilia, more than 400,000 people around the world living with the disease. Two common types of hemophilia are A and B, defects in coagulation factors 8 and 9 respectively. Hemophilia A is 80-85% of cases. Coagulation factors 8 and 9 located at the long arm of chromosome X and mutations in these genes result in the defective production of coagulation factors. Hemophilia considered an appropriate target for gene therapy, because production of 1% of normal level could adjust the phenotypic problems. Various methods have been developed for hemophilia gene therapy, producing coagulation factors in the patients ultimately. Injection of coagulation factor gene by vector into the stem cells extracted from the patients or vectors containing the transgene insertion into differentiated cells with long survival, such as muscle cells and liver are among the most important of these methods. As well as the most recent methods of gene therapy, gene transfer based on induced pluripotent stem cells is abbreviated iPS. Hepatocytes a very suitable target cells for hemophilia gene therapy because these cells are the main site of synthesis of coagulation factors. Muscle cells also are suitable for the injection of transgenes in gene therapy for hemophilia because of its appropriate secretory power and its availability. The most important and most widely used viral vectors for gene therapy of hemophilia are retroviral vectors and lentiviral and Adeno-associated viruses.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Molecular and Genetic Medicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMolecular and Genetic Medicine
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Reyhane Sadat Saeedi”
  • BylineArticles whose byline prints “Ali Hosseini Bereshneh”
  • BylineArticles whose byline prints “Saeed Tarverdizadeh”
  • BylineArticles whose byline prints “Mohammad Roshanghalb”
  • BylineArticles whose byline prints “Reza Roodbarani”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels